Inductionless or limited shock testing is possible in most patients with implantable cardioverter-defibrillators/cardiac resynchronization therapy defibrillators: Results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation with Implantable Cardioverter-Defibrillator Implantations)

Circulation

Volumn 115, Issue 18, 2007, Pages 2382-2389

  Day, John D ^a   Doshi, Rahul N ^b   Belott, Peter ^c   Birgersdotter Green, Ulrika ^d   Behboodikhah, Mahnaz ^e   Ott, Peter ^f   Glatter, Kathryn A ^g   Tobias, Serge ^h   Frumin, Howard ⁱ   Lee, Byron K ^j   Merillat, John ^k   Wiener, Isaac ^l   Wang, Samuel ^m   Grogin, Harlan ⁿ   Chun, Sung ^o   Patrawalla, Rob ^p   Crandall, Brian ^a   Osborn, Jeffrey S ^a   Weiss, J Peter ^a   Lappe, Donald L ^a   Neuman, Stacey ^q   more..

^a LDS HOSPITAL   (United States)

^b Fullerton Cardiovascular Medical Group   (United States)

^c Grossmont Hospital   (United States)

^d UCSD MEDICAL CENTER   (United States)

^e Hoag Hospital   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h Long Beach Memorial Breast Center   (United States)

ⁱ South Orange County Cardiology   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k Valley Heart Assoc Medical Group   (United States)

^l Arrhythmia Services   (United States)

^m Berkeley Cardiovascular Medical Group   (United States)

ⁿ Central Coast Cardiovascular Research   (United States)

^o PALO ALTO MEDICAL FOUNDATION RESEARCH INSTITUTE   (United States)

^p Cardiovascular Medicine and Cardiovascular Arrhythmias   (United States)

^q Medtronic Cardiac Rhythm Management   (United States)

more..

Author keywords

Defibrillation; Fibrillation; Heart failure; Shock; Tachyarrhythmias

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RISK REDUCTION; SAFETY; SCREENING; SHOCK;

AGED; AGED, 80 AND OVER; ARRHYTHMIA; CARDIOVASCULAR AGENTS; COMBINED MODALITY THERAPY; CROSS-OVER STUDIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC STIMULATION; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK REDUCTION BEHAVIOR; SINGLE-BLIND METHOD; UNNECESSARY PROCEDURES; VENTRICULAR FIBRILLATION;

EID: 34248162434     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.663112     Document Type: Article

References (24)

1. Higgins S, Mann D, Calkins H, Estes M, Strickenberger SA, Breiter D, Lang D, Hahn S. One conversion of ventricular fibrillation is adequate for implantable cardioverter-defibrillator implant: an analysis from the Low Energy Safety Study (LESS). Heart Rhythm. 2005;2:117-122.
2. Swerdlow CD. Implantation of cardioverter defibrillators without induction of ventricular fibrillation. Circulation. 2001;103:2159-2164.
3. Strickenberger J, Klein GJ. Is defibrillation testing required for defibrillator implantation? J Am Coll Cardiol. 2004;44:88-91.
4. Frame R, Brodman R, Furman S, Kim SG, Roth J, Ferrick K, Hollinger I, Gross J, Fisher JD. Clinical evaluation of the safety of repetitive intraoperative defibrillation threshold testing. Pacing Clin Electrophysiol. 1992;15:870-877.
5. Singer I, and Lang D. Defibrillation threshold: clinical utility and therapeutic implications. Pacing Clin Electrophysiol. 1992;15:932-947.
6. Vlay SC. Defibrillation threshold testing: necessary but evil? Am Heart J. 1989;117:499-504.
7. Neuzner J, Liebrich A, Jung J, Himmrich E, Pitschner HF, Winter J, Vester EG, Michel U, Nisam S, Heisel A. Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: results of the prospective, randomized, multicenter Low-Energy Endotak Trial. Am J Cardiol. 1999;83:34D-39D.
8. Sylvester E, Hoffmeister B, Johnson E, Hess P, Malkin R. Defibrillation causes immediate cardiac dilation in humans. J Cardiovasc Electrophysiol. 2003;14:832-836.
9. Rollan MJ, San Roman JA, Bratos JL, Munoz AC, Casero A, Carrasco FJ. Acute pulmonary edema secondary to myocardial damage after electrical cardioversion. Pacing Clin Electrophysiol. 2003;26:2330-2332.
10. Hasdemir C, Shah N, Rao AP, Acosta H, Matsudaira K, Neas BR, Reynolds DW, Po S, Lazzara R, Beckman KJ. Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks. J Cardiovasc Electrophysiol. 2002;13:144-150.
11. Swerdlow CD, Ahern T, Kass RM, Davie S, Mandel WJ, Chen PS. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators. J Am Coll Cardiol. 1996;27:1112-1118.
12. Swerdlow CD, Peter CT, Kass RM, Gang ES, Mandel WJ, Hwang C, Martin DJ, Chen PS. Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability. Circulation. 1997;95:1497-1504.
13. Birgersdotter-Green U, Garg A, Al-Kandari F, Ungab G, Tone L, Feld GK. Successful implantation of cardiac defibrillators without induction of ventricular fibrillation using upper limit of vulnerability testing. J Interv Cardiac Electrophysiol. 2003:8;71-75.
14. Swerdlow CD, Martin DJ, Kass RM, Davie S, Mandel WJ, Gang ES, Chen PS. The zone of vulnerability to T wave shocks in humans. J Cardiovasc Electrophysiol. 1997;8:145-154.
15. Stokes ME, Davis CS, Koch GG. Categorical Data Analysis Using the SAS System. 2nd ed. Cary, NY: SAS Institute; 2000.
16. Day JD, Doshi RN, Belott P, Birgersdotter-Green M, Behboodikhah M, Ott P, Glatter KA, Lee BK, Frumin H, Crandall BG, Osborn JS, Weiss JP, Lappe JM, Valderrabano C, Urratio C, McGuire M, Hahn S. Most patients may safely undergo inductionless or limited shock testing at ICD implantation. Heart Rhythm. 2005;2:S32. Abstract.
17. Doshi RN, Crandall BG, Osborn JS, Weiss JP, Kfoury A, Wang S, Merillat J, Patrawala R, Weiner I, Nelson J, Hunter J, McGuire M, Hahn S, Day JD. Do biventricular pacemaker defibrillator patients have higher defibrillation thresholds? Heart Rhythm. 2005;2:S243. Abstract.
18. Day JD, Olshansky B, Hahn S, McGuire M, Brown S. High defibrillation requirements are rarely encountered with modern dual chamber ICD systems. Heart Rhythm. 2005;2:S204. Abstract.
19. Chattipakorn N, Banville I, Gray RA, Ideker RE. Mechanism of ventricular defibrillation for near-defibrillation threshold shocks: a whole-heart optical mapping study in swine. Circulation. 2001;104:1313-1319.
20. Hamzei A, Ohara T, Kim YH, Lee MH, Voroshilovski O, Lin SF, Weiss JN, Chen PS, Karaqueuzian HS. The role of approximate entropy in predicting ventricular defibrillation threshold. J Cardiovasc Pharmacol Ther. 2002;7:45-52.
21. Hsia PWE, Frerk S, Allen CA, Wise RM, Cohen NM, Damiano RJ Jr. A critical period of ventricular fibrillation more susceptible to defibrillation: real-time waveform analysis using a single ECG lead. Pacing Clin Electrophysiol. 1996;19:418-430.
22. Yashima M, Kim YH, Armin S, Wu TJ, Miyauchi Y, Mandel WJ, Chen PS, Karaqueuzian HS. On the mechanism of the probabilistic nature of ventricular defibrillation threshold. Am J Physiol Heart Circ Physiol. 2003;284:H249-H255.
23. Gold MR, Breiter D, Leman R, Eric JR, Shorofsky SR, Hahn SJ. Safety of a single successful conversion of ventricular fibrillation before the implantation of cardioverter defibrillators. Pacing Clin Electrophysiol. 2003;26:483-486.
24. Mitchell LB, Pineda EA, Titus JL, Bartosch PM, Benditt DG. Sudden death in patients with implantable cardioverter defibrillators: the importance of postshock electromechanical dissociation. J Am Coll Cardiol. 2002;39:1323-1328.